Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Archives of Dermatological Research
|
February 24, 2001
SM5-1: a new monoclonal antibody which is highly sensitive and specific for melanocytic lesions
U Trefzer, N Rietz, Y Chen, et al.
Endoscopy
|
May 28, 2011
Algorithm for detection of small-bowel metastasis in malignant melanoma of the skin
J G Albert, M Fechner, E Fiedler, et al.
The British Journal of Dermatology
|
December 16, 2014
Actual practice of melanoma follow-up and treatment in Germany: results of a prospective, longitudinal cohort study
E Livingstone, T K Eigentler, C Windemuth-Kieselbach, et al.
Nature Medicine
|
March 4, 2000
Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids
A Kugler, G Stuhler, P Walden, et al.
The British Journal of Dermatology
|
September 24, 2019
Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT study
R Dummer, A Guminksi, R Gutzmer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 12, 2011
Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial
F Egberts, R Gutzmer, S Ugurel, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 29, 2017
Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study
J T Lear, M R Migden, K D Lewis, et al.
British Journal of Cancer
|
July 14, 2011
A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma
S O'Day, A Pavlick, C Loquai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 8, 2014
Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC study
D Schadendorf, M M Amonkar, M Milhem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 8, 2014
Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma
B Schilling, W Sondermann, F Zhao, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Archives of Dermatological Research
|
February 24, 2001
SM5-1: a new monoclonal antibody which is highly sensitive and specific for melanocytic lesions
U Trefzer, N Rietz, Y Chen, et al.
Endoscopy
|
May 28, 2011
Algorithm for detection of small-bowel metastasis in malignant melanoma of the skin
J G Albert, M Fechner, E Fiedler, et al.
The British Journal of Dermatology
|
December 16, 2014
Actual practice of melanoma follow-up and treatment in Germany: results of a prospective, longitudinal cohort study
E Livingstone, T K Eigentler, C Windemuth-Kieselbach, et al.
Nature Medicine
|
March 4, 2000
Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids
A Kugler, G Stuhler, P Walden, et al.
The British Journal of Dermatology
|
September 24, 2019
Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT study
R Dummer, A Guminksi, R Gutzmer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 12, 2011
Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial
F Egberts, R Gutzmer, S Ugurel, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 29, 2017
Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study
J T Lear, M R Migden, K D Lewis, et al.
British Journal of Cancer
|
July 14, 2011
A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma
S O'Day, A Pavlick, C Loquai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 8, 2014
Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC study
D Schadendorf, M M Amonkar, M Milhem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 8, 2014
Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma
B Schilling, W Sondermann, F Zhao, et al.
Page
of 5